186 related articles for article (PubMed ID: 7477193)
21. The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
De Reuck J; Van Vleymen B
Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():33-7. PubMed ID: 10338106
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
Prandoni P; Carnovali M; Marchiori A;
Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
[TBL] [Abstract][Full Text] [Related]
23. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
[TBL] [Abstract][Full Text] [Related]
24. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.
Agnelli G; Gussoni G; Bianchini C; Verso M; Mandalà M; Cavanna L; Barni S; Labianca R; Buzzi F; Scambia G; Passalacqua R; Ricci S; Gasparini G; Lorusso V; Bonizzoni E; Tonato M;
Lancet Oncol; 2009 Oct; 10(10):943-9. PubMed ID: 19726226
[TBL] [Abstract][Full Text] [Related]
25. Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study.
He L; Chen X; Zhou M; Zhang D; Yang J; Yang M; Zhou D
Phytomedicine; 2011 Apr; 18(6):437-42. PubMed ID: 21094030
[TBL] [Abstract][Full Text] [Related]
26. Thrombolytic therapy with streptokinase in acute ischemic stroke.
; Hommel M; Cornu C; Boutitie F; Boissel JP
N Engl J Med; 1996 Jul; 335(3):145-50. PubMed ID: 8657211
[TBL] [Abstract][Full Text] [Related]
27. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
Cooperative Group for Reassessment of Defibrase
Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
[TBL] [Abstract][Full Text] [Related]
28. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators.
Diener HC; Ringelstein EB; von Kummer R; Langohr HD; Bewermeyer H; Landgraf H; Hennerici M; Welzel D; Gräve M; Brom J; Weidinger G
Stroke; 2001 Jan; 32(1):22-9. PubMed ID: 11136909
[TBL] [Abstract][Full Text] [Related]
29. Low-molecular-weight heparin versus aspirin for acute ischemic stroke with large artery occlusive disease: subgroup analyses from the Fraxiparin in Stroke Study for the treatment of ischemic stroke (FISS-tris) study.
Wang QS; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
Stroke; 2012 Feb; 43(2):346-9. PubMed ID: 22076004
[TBL] [Abstract][Full Text] [Related]
30. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
Dumas R; Woitinas F; Kutnowski M; Nikolic I; Berberich R; Abedinpour F; Zoeckler S; Gregoire F; Jerkovic M; Egberts JF
Age Ageing; 1994 Nov; 23(6):512-6. PubMed ID: 9231947
[TBL] [Abstract][Full Text] [Related]
31. Nadroparin therapy in pediatric patients with venous thromboembolic disease.
van Ommen CH; van den Dool EJ; Peters M
J Pediatr Hematol Oncol; 2008 Mar; 30(3):230-4. PubMed ID: 18376287
[TBL] [Abstract][Full Text] [Related]
32. Effect of propentofylline on regional cerebral glucose metabolism in acute ischemic stroke.
Huber M; Kittner B; Hojer C; Fink GR; Neveling M; Heiss WD
J Cereb Blood Flow Metab; 1993 May; 13(3):526-30. PubMed ID: 8478410
[TBL] [Abstract][Full Text] [Related]
33. Clinical study on low-molecular weight heparin infusion as anticoagulation for nocturnal home haemodialysis.
Wong SS; Lau WY; Ng ML; Chan SY; Chan SF; Chan PK; Wan CK; Cheng YL
Nephrology (Carlton); 2018 Apr; 23(4):317-322. PubMed ID: 28052451
[TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study.
Wong KS; Chen C; Ng PW; Tsoi TH; Li HL; Fong WC; Yeung J; Wong CK; Yip KK; Gao H; Wong HB;
Lancet Neurol; 2007 May; 6(5):407-13. PubMed ID: 17434095
[TBL] [Abstract][Full Text] [Related]
35. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.
Saxena R; Lewis S; Berge E; Sandercock PA; Koudstaal PJ
Stroke; 2001 Oct; 32(10):2333-7. PubMed ID: 11588322
[TBL] [Abstract][Full Text] [Related]
36. Pilot study of low-molecular-weight heparin in the treatment of acute ischemic stroke.
Kay R; Wong KS; Woo J
Stroke; 1994 Mar; 25(3):684-5. PubMed ID: 8128526
[TBL] [Abstract][Full Text] [Related]
37. [Calcium nadroparin in the prevention of thromboembolic disease in elderly subjects. Study of tolerance].
Forette B; Wolmark Y
Presse Med; 1995 Mar; 24(12):567-71. PubMed ID: 7770402
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.
De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM
Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612
[TBL] [Abstract][Full Text] [Related]
39. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
Bloom JM
N Engl J Med; 1996 May; 334(21):1407. PubMed ID: 8614440
[No Abstract] [Full Text] [Related]
40. Low-molecular-weight heparins and heparinoids and their use in acute or progressing ischemic stroke.
Gordon DL; Linhardt R; Adams HP
Clin Neuropharmacol; 1990 Dec; 13(6):522-43. PubMed ID: 1703455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
